Biolchim S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Biolchim S.p.A. - overview
Established
1972
Location
Bologna, -, Italy
Primary Industry
Chemicals
About
Biolchim S. p. A. is a Bologna-based company specializing in the development and commercialization of nutritional specialties and biostimulants, aimed at enhancing agricultural productivity and addressing specific crop growth challenges.
Founded in 1972 in Bologna, Italy, Biolchim S. p. A. formulates agricultural solutions that enhance productivity.
The company was acquired by JM Huber Corporation in August 2022, expanding its global reach. Leonardo Valenti continues as CEO, steering the company forward with innovative practices. Biolchim has been involved in 3 funding rounds, with the latest being a Buyout round of EUR 21. 000 mn, raising a total of EUR 21.
000 mn from investors including Wise Equity. Biolchim specializes in innovative biostimulants and nutritional specialties that enhance agricultural productivity. Their products address challenges such as optimizing crop growth under adverse conditions, particularly in table grape and blueberry cultivation. Biolchim serves a diverse clientele including agricultural producers across Italy, Spain, Germany, Brazil, Hungary, Poland, China, New Zealand, and Australia, with a commitment to transforming scientific research into practical agricultural solutions through its Worldwide Innovation Network (WIN).
In 2023, Biolchim reported a revenue of EUR 61,931,710. 90 and an EBITDA of EUR 13,413,297. 80. The company's B2B model focuses on partnerships with agricultural retailers and wholesalers to distribute its high-quality products directly to farmers, ensuring tailored solutions that meet specific agronomic needs.
Biolchim is poised for growth following its acquisition by JM Huber Corporation, which aims to enhance both companies’ global footprint and product offerings. The utilization of the EUR 21. 000 mn from the recent Buyout round will support the development of new products and expansion into additional markets. Future initiatives include targeting new geographic regions for market entry and leveraging innovative agricultural solutions to meet evolving demands.
Primary Industry
Chemicals
Sub Industries
Logistics & Distribution, Agricultural Chemicals
Website
www.biolchim.com
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Biolchim S.p.A. - timeline of key events
Biolchim S.p.A. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 38,000,000 | - | 35,068,252 | 39,428,949 | 42,256,157 | 44,473,770 | 44,812,592 | 46,181,683 | 46,069,091 | 49,468,966 | 57,002,663 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 12.4% | 7.2% | 5.2% | 0.8% | 3.1% | (0.2%) | 7.4% | 15.2% | - | - | - |
| EBITDA (USD) | 4,000,000 | - | 4,223,897 | 7,167,732 | 8,176,888 | 10,182,753 | 10,869,870 | 10,001,246 | 10,443,181 | 11,704,970 | 14,486,332 | - | - | - |
| Operating Income (USD) | - | - | 3,662,336 | 6,399,806 | 7,307,785 | 9,403,640 | 10,078,728 | 6,466,516 | 6,775,662 | 8,099,154 | 10,907,932 | - | - | - |
| Operating Margin | - | - | 10.4% | 16.2% | 17.3% | 21.1% | 22.5% | 14.0% | 14.7% | 16.4% | 19.1% | - | - | - |
| % EBITDA Margin | 10.5% | - | 12.0% | 18.2% | 19.4% | 22.9% | 24.3% | 21.7% | 22.7% | 23.7% | 25.4% | - | - | - |
| NET Income (USD) | - | - | 1,789,567 | 3,717,110 | 3,090,181 | 7,087,336 | 6,413,505 | 3,880,684 | 3,186,080 | 20,490,779 | 7,537,694 | - | - | - |
| % Net Margin | - | - | 5.1% | 9.4% | 7.3% | 15.9% | 14.3% | 8.4% | 6.9% | 41.4% | 13.2% | - | - | - |
Biolchim S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Biolchim S.p.A. | - | ||||||||
| Secondary Buyout | Completed | Biolchim S.p.A. | - | ||||||||
| Add-on | Completed | ILSA | - | ||||||||
| Add-on | Completed | Matécsa Kft | - | ||||||||
| Add-on | Completed | West Coast Marine-Bio Processing | - |
Displaying 1 - 5 of 7
Biolchim S.p.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.